McCormick & Company, Incorporated

- The transaction is being financed through a combination of new financing and new debt, rather than absorbing any existing debt from Unilever. - McCormick is issuing a fixed number of shares as consideration for Unilever Foods, resulting in Unilever and its shareholders owning 65% of the combined company and McCormick shareholders retaining 35%. - In addition, McCormick will pay $15.7 billion in cash to Unilever as part of the deal. - The deal results in McCormick having a leverage ratio of about 4x at closing. - The plan includes rapid deleveraging from 4x to approximately 3x leverage within two years, supported by strong cash generation and disciplined execution. - The financing structure balances debt and equity to optimize value and maintain financial flexibility for the combined company.

- The combined company plans to reinvest incremental revenue and cost synergies back into the business to accelerate growth. - Approximately $100 million will be reinvested into brands through increased marketing to support innovation and fuel sustained volume growth. - There is a focus on expanding innovation capabilities as part of the long-term strategy. - Continued investments are expected to support strong brand momentum and growth. - The company aims to maintain a strong investment profile while managing disciplined capital allocation. - Financial flexibility is preserved to support ongoing investments despite the leverage targets and debt financing taken for the transaction. - The integration includes significant commercial agenda shaping to unlock portfolio growth from the outset, suggesting ongoing strategic investments in market expansion and brand development.

- Combined company expects sustainable organic sales growth of 3% to 5% by year 3 post-close. - Current combined organic sales growth is around 2.4%, with an anticipated acceleration to 2% to 3% in the near term. - Incremental growth towards year 3 is expected to come largely from self-help initiatives rather than just industry improvement. - Growth opportunities are broad, spanning multiple regions including North America, Latin America, EMEA, and Asia Pacific. - Expansion of high-growth potential brands like Cholula and MAI across new geographies and channels will drive revenue growth. - Leveraging Unilever Foods’ presence in new markets and channels presents additional volume and revenue opportunities. - Innovation capabilities combining McCormick’s and Unilever’s R&D aim to accelerate speed to market and meet evolving consumer dietary needs. - Food Service business expansion adds approximately $6 billion in pro forma annual sales, enhancing dual-channel growth.

- The combination is expected to be meaningfully accretive to earnings per share (EPS) in the first full year post-close across all P&L lines, including EPS. - Operating profit is projected to grow from 21% currently to a range of 23% to 25% with $600 million in annual run rate cost synergies by year 3. - Sustainable organic sales growth of 3% to 5% is anticipated by year 3, supported by brand reinvestment and enhanced innovation. - Synergies of $600 million are expected by year 3, with about two-thirds realized by the end of year 2. - Incremental revenue and cost synergies will be reinvested (~$100 million) into marketing and innovation to accelerate growth. - The transaction delivers meaningful accretion in sales growth, adjusted operating margin, and adjusted earnings per share from the first full year. - Long-term thinking emphasizes strong margin expansion, volume-driven growth, and resilient cash flow generation.

The provided transcript and presentation pages from the McCormick & Company Q1 2026 Earnings Call do not contain specific information regarding current, expected order book, or pending orders. The discussion focuses primarily on: - Strategic rationale and details of McCormick's combination with Unilever Foods. - Synergy targets and integration plans. - Financial outlook, including expected sales growth, margins, and cost synergies. - Market positioning, portfolio expansion, and innovation capabilities. - The transaction structure and expected shareholder benefits. No explicit details on order book status, volume of pending orders, or backlog figures are mentioned in the available content. If this information is critical, please provide additional sections or documents that specifically address order books or pending orders.